-+ 0.00%
-+ 0.00%
-+ 0.00%

Heartsciences Inc. Reports Minimal Revenues for Q3 2025; Research and Development Expenses Decrease by 19% Compared to Q3 2024

Reuters·09/11/2025 20:06:14

Please log in to view news